Artificial Neural Networks: Comparison of two programs for modeling a process of nanoparticle preparation

Drug Development and Industrial Pharmacy

Volumn 31, Issue 10, 2005, Pages 1019-1033

  Rizkalla, Névine ^a   Hildgen, Patrice ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Artificial neural networks; Genetic algorithm; Nanoparticles; Network architecture; Polynomial regression

Indexed keywords

DRUG CARRIER; NANOPARTICLE; POLYLACTIC ACID;

ARTICLE; ARTIFICIAL NEURAL NETWORK; COMPUTER ANALYSIS; COMPUTER MODEL; COMPUTER PREDICTION; COMPUTER PROGRAM; EMULSION; GENETIC ALGORITHM; LINEAR REGRESSION ANALYSIS; NONLINEAR SYSTEM; PARTICLE SIZE; POLYMER PRODUCTION; STATISTICAL ANALYSIS; SURFACE PROPERTY;

DRUG COMPOUNDING; FUZZY LOGIC; GENETICS; MODELS, STATISTICAL; NANOSTRUCTURES; NEURAL NETWORKS (COMPUTER); NEURONS; PARTICLE SIZE; POROSITY; PRINCIPAL COMPONENT ANALYSIS; RANDOM ALLOCATION; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SOFTWARE;

EID: 28744450132     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500306294     Document Type: Article

References (32)

1. Achanta, A. S., Kowalski, J. G., & Rhodes, C. T. (1995). Artificial neural networks: implications for pharmaceutical sciences. Drug Development and Industrial Pharmacy, 21, 119-155.
2. Agatonovic-Kustrin, S., & Alany, R. G. (2001). Role of genetic algorithms and artificial neural networks in predicting the phase behavior of colloidal delivery systems. Pharmaceutical Research, 18, 1049-1055.
3. Agatonovic-Kustrin, S., & Beresford, R. (2000). Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. Journal of Pharmaceutical and Biomedical Analysis, 22, 717-727.
4. Bourquin, J., Schmidli, H., van Hoogevest, P., & Leuenberger, H. (1997). Basic concepts of artificial neural networks (ANN) modeling in the application to pharmaceutical development. Pharmaceutical Development and Technology, 2, 95-109.
5. Bourquin, J., Schmidli, H., Van Hoogevest, P., & Leuenberger, H. (1998). Comparison of artificial neural networks (ANN) with classical modelling techniques using different experimental designs and data from a galenical study on a solid dosage form. European Journal of Pharmaceutical Sciences, 6, 287-300.
6. Carpenter, W. C., & Hoffman, M. E. (1995). Understanding neural network approximations and polynomial approximations help neural network performance. Al Expert, 10, 31-33.
7. Chorny, M., Fishbein, I., Danenberg, H. D., & Golomb, G. (2002). Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. Journal of Controlled Release, 83, 389-400.
8. Das, S. K., Tucker, I. G., & Ganguly, N. (1995). Evaluation of poly(isobutylcyanoacrylate) nanoparticles for mucoadhesive ocular drug delivery. I. Effect of formulation variables on physicochemical characteristics of nanoparticles. Pharmaceutical Research, 12, 534-540.
9. Fan, T., Takayama, K., Hattori, Y., & Maitani, Y. (2004). Formulation optimization of paclitaxel carried by PEGylated emulsions based on artificial neural network. Pharmaceutical Research, 21, 1692-1697.
10. Haykin, S. (1999). Neural Networks a Comprehensive Foundation (2nd ed.). Upper Saddle River, NJ: Prentice-Hall, Inc..
11. Hussein, A. S., Xuanqjang, Y., & Johnson, R. D. (1991). Application of neural computing in pharmaceutical product development. Pharmaceutical Research, 8, 1248-1252.
12. Ibrić, S., Jovanović, M., Djurić, Z., Parojčić, J., & Solomun, L. (2002). The application of generalized regression neural network in the modeling and optimization of aspirin extended release tablets with Eudragit RS PO as matrix substance. Journal of Controlled Release, 82, 213-222.
13. Jamshidi, M. (2003). Tools for intelligent control: fuzzy controllers, neural networks and genetic algorithms. Philosophical Transactions of the Royal Society of London, A, 361, 1781-1808.
14. Lamprecht, A., Ubrich, N., Hombreiro Pérez, M., Lehr, C.-M., Hoffman, M., & Maincent, P. (2000). Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. International Journal of Pharmaceutics, 196, 177-182.
15. Lescure, F., Zimmer, C., Roy, R., & Couvreur, P. (1992). Optimization of poly(alkylcyanoacrylate) nanoparticles: influence of sulphur dioxide and pH on nanoparticles characteristics. Journal of Colloid and Interface Science, 154, 77-86.
16. Mainardes, R. M., & Evangelista, R. C. (2005). PLGA nanoparticles containing praziquantel: effect of formulation variables. International Journal of Pharmaceutics, 290, 137-144.
17. McCarron, P. A., Woolfson, A. D., & Keating, S. M. (1999). Response surface methodology as a predictive tool for determining the effects of preparation conditions on the physicochemical properties of poly(isobutylcyanoacrylate) nanoparticles. International Journal of Pharmaceutics, 193, 37-47.
18. Pen, K. K., Lim, C. P., Queck, S. S., & Khoh, K. H. (2000). Use of artificial neural networks to predict drug dissolution profiles and evaluation of network performance using similarity factor. Pharmaceutical Research, 17, 1384-1388.
19. Quantachrome (2003). Autosorb-1 Operating Manual, Version 1.27. Quantachrome Instruments, Boysiton Beach, Florida, USA.
20. Reis, M. A. A., Sinisterra, R. D., & Belchior, J. C. (2003). An alternative approach based on artificial neural networks to study controlled drug release. Journal of Pharmaceutical Sciences, 93, 418-430.
21. Rizkalla, N., Range, C., Lacasse, F.-X., & Hildgen, P. Effect of various formulation parameters on the properties of polymeric nanoparticles prepared by multiple emulsion method, in press.
22. Sathe, P. M., & Venitz, J. (2003). Comparison of neural network and multiple linear regression as dissolution predictors. Drug Development and Industrial Pharmacy, 29, 349-355.
23. Seijo, B., Fattal, E., Roblot-Treupel, L., & Couvreur, P. (1990). Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading. International Journal of Pharmaceutics, 62, 1-7.
24. Sun, Y., Peng, Y., Chen, Y., & Shukla, A. J. (2003). Application of artificial neural networks in the design of controlled release delivery systems. Advanced Drug Delivery Reviews, 55, 1201-1215.
25. Takahara, J., Takayama, K., & Nagai, T. (1997). Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations. Journal of Controlled Release, 49, 11-20.
26. Takayama, K., Fujikawa, M., & Nagai, T. (1999). Artificial neural network as a novel method to optimize pharmaceutical formulations. Pharmaceutical Research, 16, 1-6.
27. Türkoǧlu, M., Ozarslan, R., & Sakr, A. (1995). Artificial neural network analysis of a direct compression tabletting study. European Journal of Pharmaceutics and Biopharmaceutics, 41, 315-322.
28. Türkoǧlu, M., Aydin, I., Murray, M., & Sakr, A. (1999). Modeling of a roller-compaction process using neural networks and genetic algorithms. European Journal of Pharmaceutics and Biopharmaceutics, 48, 239-245.
29. Vandervoort, J., & Ludwig, A. (2001). Preparation factors affecting the properties of polylactide nanoparticles: a factorial design study. Pharmazie, 56, 484-488.
30. Yüksel, N., Türkoǧlu, M., & Baykara, T. (2000). Modelling of the solvent evaporation method for the preparation of controlled release acrylic microspheres using neural networks. Journal of Microencapsulation, 17, 541-551.
31. Zambaux, M. F., Bonneaux, F., Gref, R., Maincent, P., Dellacherie, E., Alonso, M. J., Labrude, P., & Vigneron, C. (1998). Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. Journal of Controlled Release, 50, 31-40.
32. Zweers, M. L. T., Grijpma, D. W., Engbers, G. H. M., & Feijen, J. (2003). The preparation of monodisperse biodegradable polyester nanoparticles with a controlled size. Journal of Biomedical Materials Research, 66B, 559-566.